Literature DB >> 34704409

Eye diseases burden in China in the past 30 years.

Binbin Chen1, Lixia Lou1, Juan Ye1.   

Abstract

To investigate the national burden of eye diseases in China from 1990 to 2019. The national burden of eye diseases in China, including case numbers, prevalence rate, age-standardized prevalence rate (ASR), disability-adjusted life year (DALY), DALY rate and age-standardized DALY rate (ASD) were calculated and stratified by sex and age. The trends of eye diseases burden from 1990 to 2019 and the correlation between eye diseases burden and human development index (HDI) were analyzed. In 2019, the total case number of eye diseases in China was 0.21 billion, the ASR was 9511/10, the total number of DALY was 4.72 million, and the ASD was 247.4/10. Near vision loss caused the greatest burden, followed by refraction disorders and cataract, with ASD being 73.8/10, 70.3/10 and 59.2/10, respectively. Men had lower risks of eye diseases than women. People aged old and old had the greatest burden of eye diseases. Compared with the year 1990, the total case number increased by 134.6% and DALY by 113.0% in 2019. The ASD of all decreased by 7.5%, and was negatively correlated with national HDI. Near vision loss, refraction disorders and cataract are of heavy disease burden in China. Although the ASD of eye diseases is decreased with the development of the national socioeconomic status, the eye diseases burden in China still increased with population growth and aging.

Entities:  

Keywords:  Burden of disease; Disability-adjusted life year; Eye disease; Human development index; Prevalence

Mesh:

Year:  2021        PMID: 34704409      PMCID: PMC8714487          DOI: 10.3724/zdxbyxb-2021-0246

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  12 in total

1.  Prevalence of glaucoma in North China: the Beijing Eye Study.

Authors:  Ya Xing Wang; Liang Xu; Hua Yang; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2010-10-20       Impact factor: 5.258

2.  Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou.

Authors:  Mingguang He; Paul J Foster; Jian Ge; Wenyong Huang; Yingfeng Zheng; David S Friedman; Pak Sang Lee; Peng T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

Review 3.  [Analysis of the prevalence of blindness and major blinding diseases in China].

Authors:  H Gao; X N Chen; W Y Shi
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2019-08-11

4.  Bronchoscopic Thermal Vapour Ablation: Hot Stuff to Treat Emphysema Patients!

Authors:  Arschang Valipour
Journal:  Arch Bronconeumol       Date:  2016-12-02       Impact factor: 4.872

5.  Effect of Community Screening on the Demographic Makeup and Clinical Severity of Glaucoma Patients Receiving Care in Urban China.

Authors:  Yuanbo Liang; Junhong Jiang; Wen Ou; Xianyao Peng; Ruizhu Sun; Xiang Xu; Juanyuan Yang; Cheng Hu; Cong Ye; Nathan Congdon; Fan Lu
Journal:  Am J Ophthalmol       Date:  2018-07-25       Impact factor: 5.258

6.  [The epidemic status and secular trends of myopia prevalence for Chinese children and adolescents aged 7-18 years from 2005 to 2014].

Authors:  Y H Dong; H B Liu; Z H Wang; R B Xu; Z P Yang; J Ma
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2017-04-06

7.  Prevalence of Vision Impairment in Older Adults in Rural China in 2014 and Comparisons With the 2006 China Nine-Province Survey.

Authors:  Jialiang Zhao; Xiao Xu; Leon B Ellwein; Ning Cai; Huaijin Guan; Mingguang He; Ping Liu; Jianhua Lv; Xunlun Sheng; Peizeng Yang; Jinglin Yi; Mei Yang; Rui Zhang; Xiaohu Ding; Liping Du; Fengrong Li; Hong Lu; Wenqiang Shao; Junwei Wang; Yuansheng Yuan; Rui Zhou; Wenjuan Zhuang; Lei An
Journal:  Am J Ophthalmol       Date:  2017-11-02       Impact factor: 5.258

8.  Causes of Visual Impairment and Blindness in the 2006 and 2014 Nine-Province Surveys in Rural China.

Authors:  Jialiang Zhao; Xiao Xu; Leon B Ellwein; Huaijin Guan; Mingguang He; Ping Liu; Jianhua Lv; Xunlun Sheng; Peizeng Yang; Jinglin Yi; Ning Cai; Mei Yang; Miaomiao Chen; LiangLiang Deng; Xiaohu Ding; Liping Du; Fengrong Li; Xian Liu; Hong Lu; Changliang Shao; Junwei Wang; Wenjuan Zhuang; Lei An
Journal:  Am J Ophthalmol       Date:  2018-09-19       Impact factor: 5.258

Review 9.  Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.

Authors:  Seth R Flaxman; Rupert R A Bourne; Serge Resnikoff; Peter Ackland; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor
Journal:  Lancet Glob Health       Date:  2017-10-11       Impact factor: 26.763

Review 10.  Elimination of avoidable blindness due to cataract: where do we prioritize and how should we monitor this decade?

Authors:  Gudlavalleti V S Murthy; Neena John; Bindiganavale R Shamanna; Hira B Pant
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

View more
  1 in total

Review 1.  Effects of Lycium barbarum L. Polysaccharides on Vascular Retinopathy: An Insight Review.

Authors:  Chunhong Yang; Qi Zhao; Shiling Li; Lili Pu; Liqiong Yu; Yaqin Liu; Xianrong Lai
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.